Romulus Titan

Romulus Titan is a private biotechnology company based in Oxford, Mississippi, primarily known for its joint venture with Cloaked Therapeutics to develop the TumorSelect cancer chemotherapy platform. The company's technology focuses on improving the delivery of chemotherapeutic agents, such as taxanes, by utilizing proprietary prodrugs and nanotechnology that exploit the high cholesterol demands of tumor cells. By disguising toxic drugs within nanoparticulates that mimic cholesterol, the TumorSelect platform aims to increase drug concentration within tumors while sparing healthy tissues, thereby reducing systemic side effects. Romulus Titan collaborates closely with researchers from the University of Mississippi's National Center for Natural Products Research (NCNPR) to advance its pre-clinical oncology programs.